Profile data is unavailable for this security.
About the company
Align Technology, Inc. designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment. The Clear Aligner segment consists of its Invisalign System, which includes Invisalign Full, Teen and Assist (Comprehensive Products), Express/Lite (Non-Comprehensive Products) and Vivera Retainers, along with its training and ancillary products for treating malocclusion (Non-Case). The Scanner segment consists of intra-oral scanning systems and other services available with the intra-oral scanners that provide digital alternatives to the traditional cast models. The Scanner segment includes its iTero scanner and OrthoCAD services.
- Revenue in USD (TTM)1.73bn
- Net income in USD339.19m
- Incorporated1997
- Employees8.72k
- LocationAlign Technology Inc2820 Orchard PkwySAN JOSE 95134-2019United StatesUSA
- Phone+1 (408) 470-1000
- Fax+1 (408) 470-1010
- Websitehttp://www.aligntech.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Inc. | 2.34bn | 453.58m | 16.24bn | 5.94k | 36.12 | 7.89 | 28.32 | 6.94 | 3.15 | 2.19 | 16.26 | 14.43 | 0.7165 | 3.64 | 5.01 | 393,972.40 | 13.89 | 13.28 | 16.02 | 15.61 | 58.21 | 59.41 | 19.38 | 19.48 | 1.56 | 42.29 | 0.1203 | 46.18 | 13.23 | 9.09 | 32.52 | 8.11 | -0.0907 | 15.54 |
| ABIOMED, Inc. | 641.29m | 186.26m | 17.27bn | 1.14k | 95.17 | 23.88 | 87.34 | 26.93 | 4.04 | 3.58 | 13.95 | 16.12 | 0.8759 | 2.32 | 10.59 | 561,059.50 | 25.44 | 17.28 | 28.04 | 19.66 | 83.23 | 83.34 | 29.04 | 19.35 | 5.76 | -- | 0.00 | 0.00 | 33.34 | 30.29 | 156.29 | 54.83 | 81.50 | -- |
| IDEXX Laboratories, Inc. | 2.12bn | 337.91m | 20.88bn | 7.60k | 63.45 | -- | 49.49 | 9.87 | 3.80 | 3.45 | 23.79 | -0.4746 | 1.34 | 5.40 | 8.38 | 278,487.50 | 21.40 | 15.34 | 48.93 | 33.36 | 55.85 | 55.25 | 15.97 | 13.13 | 0.7275 | 13.65 | 1.05 | 0.00 | 10.91 | 8.77 | 32.47 | 10.53 | 5.56 | -- |
| Zimmer Biomet Holdings Inc | 7.92bn | 417.50m | 26.74bn | 18.20k | 64.38 | 2.22 | 18.13 | 3.38 | 2.04 | 8.28 | 38.75 | 59.24 | 0.3048 | 1.09 | 5.74 | 435,033.00 | 1.61 | 2.75 | 1.78 | 3.02 | 71.14 | 71.34 | 5.29 | 8.08 | 1.25 | 5.47 | 0.4413 | 33.44 | 1.82 | 11.84 | 76.99 | -6.43 | 13.26 | 5.92 |
| Align Technology, Inc. | 1.73bn | 339.19m | 30.59bn | 8.72k | 91.78 | 25.09 | 78.51 | 17.64 | 4.15 | 3.61 | 21.21 | 15.18 | 0.9999 | 10.45 | 5.21 | 198,941.30 | 19.87 | 15.31 | 27.83 | 20.04 | 75.18 | 75.69 | 19.87 | 17.93 | 2.14 | -- | 0.00 | 0.00 | 36.44 | 21.34 | 66.45 | 40.01 | 38.55 | -- |
| Edwards Lifesciences Corp | 3.55bn | 925.10m | 32.18bn | 12.20k | 35.48 | 10.16 | 32.01 | 9.07 | 4.33 | 3.05 | 16.58 | 15.13 | 0.6556 | 1.75 | 7.53 | 290,860.70 | 17.09 | 16.77 | 20.38 | 19.54 | 73.84 | 74.12 | 26.07 | 23.70 | 1.80 | -- | 0.2738 | 0.00 | 15.91 | 12.58 | 54.12 | 24.66 | 8.63 | -- |
| Baxter International Inc | 11.00bn | 1.50bn | 41.34bn | 47.00k | 28.20 | 4.66 | 18.18 | 3.76 | 2.74 | 1.65 | 20.02 | 16.60 | 0.6559 | 4.03 | 6.28 | 234,042.50 | 8.97 | 6.98 | 10.60 | 8.97 | 42.39 | 42.14 | 13.67 | 14.64 | 2.00 | 44.85 | 0.2829 | 46.63 | 3.92 | -5.40 | -73.64 | -10.53 | -11.40 | -17.23 |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Jun 2018 | 7.93m | 9.87% |
| BlackRock Fund Advisorsas of 30 Jun 2018 | 3.69m | 4.59% |
| Sands Capital Management LLCas of 30 Jun 2018 | 3.06m | 3.81% |
| Renaissance Technologies LLCas of 30 Jun 2018 | 2.89m | 3.60% |
| SSgA Funds Management, Inc.as of 30 Jun 2018 | 2.85m | 3.54% |
| Polen Capital Management LLCas of 30 Jun 2018 | 2.37m | 2.95% |
| Fidelity Management & Research Co.as of 30 Jun 2018 | 1.66m | 2.06% |
| Invesco Capital Management LLCas of 30 Jun 2018 | 1.13m | 1.40% |
| T. Rowe Price Associates, Inc.as of 30 Jun 2018 | 1.09m | 1.36% |
| Geode Capital Management LLCas of 30 Jun 2018 | 994.25k | 1.24% |
